Literature DB >> 15297210

Hematogenous rectal metastasis 20 years after removal of epithelial ovarian cancer.

Cynthia Trastour1, Amine Rahili, Charlotte Schumacker, Ahoua Benjamin Effi, Jean-Louis Bernard.   

Abstract

BACKGROUND: Rectal tumors are rarely metastatic. Moreover, hematogenous spread is rare in ovarian cancer whose dissemination frequently occurs through peritoneal or lymphatic ways. CASE: A 55-year-old female presented with a rectal metastasis that appeared 20 years after the treatment of a primary clear cell carcinoma of the ovary. The cytokeratin 7 positive/cytokeratin 20 negative immunophenotype assessed the ovarian origin of the rectal tumor. Because of the integrity of the rectal serosa and the uninvolved mesenteric lymph nodes, we hypothesize our rectal metastasis to come from the hematogenous way.
CONCLUSION: This is the first reported case of hematogenous rectal metastasis in epithelial ovarian carcinoma and that, with so late delay.

Entities:  

Mesh:

Year:  2004        PMID: 15297210     DOI: 10.1016/j.ygyno.2004.05.022

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  3 in total

1.  Case Report: Mammary and rectal metastases from an ovarian cancer: report of two cases and review of literature.

Authors:  Mounia Amzerin; Camilo Garcia; Claudia Stanciu; Isabelle Veys; Ahmad Awada; Hassan Errihani; Andrea Gombos
Journal:  F1000Res       Date:  2014-10-28

2.  A case of rectal metastasis of ovarian carcinoma diagnosed by endoscopic ultrasound-guided fine-needle aspiration: A case report and brief review of the literature (with videos).

Authors:  Jialiang Huang; Liming Xu; Guilian Cheng; Wei Wu; Wen Tang; Longjiang Xu; Duanmin Hu
Journal:  Clin Case Rep       Date:  2021-03-05

3.  Successful treatment of recurrent rectal implantation metastasis of ovarian cancer by natural orifice specimen extraction surgery: a case report.

Authors:  Hao Su; Bin Li; Wenhao Ren; Mandula Bao; Peng Wang; Qian Liu; Xishan Wang; Zhixiang Zhou; Haitao Zhou
Journal:  Onco Targets Ther       Date:  2018-09-17       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.